15 CFR Appendix Supplement No. 3 to Part 740 - Supplement No. 3 to Part 740—License Exception ENC Favorable Treatment Countries
Supplement No. 3 to Part 740—License Exception ENC Favorable Treatment Countries
Austria
Australia
Belgium
Bulgaria
Canada
Croatia
Cyprus
Czech Republic
Estonia
Denmark
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Japan
Latvia
Lithuania
Luxembourg
Malta
Netherlands
New Zealand
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
United Kingdom